AcouSort AB (publ) (STO:ACOU)
Sweden · Delayed Price · Currency is SEK 2.280
+0.010 (0.44%)
Mar 4, 2026, 5:12 PM CET
AcouSort AB Market Cap
AcouSort AB has a market cap or net worth of 48.25 million as of March 4, 2026. Its market cap has decreased by -63.53% in one year.
Market Cap
48.25M
Enterprise Value
41.96M
Revenue
10.43M
Ranking
n/a
PE Ratio
n/a
Stock Price
2.28
Market Cap Chart
Since January 9, 2017, AcouSort AB's market cap has decreased from 65.36M to 48.25M, a decrease of -26.17%. That is a compound annual growth rate of -3.26%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 4, 2026 | 48.25M | -19.43% |
| Dec 30, 2025 | 59.89M | -63.54% |
| Dec 30, 2024 | 164.28M | -29.12% |
| Dec 29, 2023 | 231.76M | 18.13% |
| Dec 30, 2022 | 196.19M | -41.95% |
| Dec 30, 2021 | 337.98M | 24.44% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Jan 9, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Alligator Bioscience AB | 102.73M |
| Biosergen AB | 90.17M |
| Scandinavian ChemoTech AB | 89.09M |
| OncoZenge AB | 78.54M |
| Spago Nanomedical AB | 78.07M |
| Alzinova AB | 64.05M |
| Pila Pharma AB | 57.56M |
| 2cureX AB | 40.29M |